Cargando…
Cdh1-mediated Skp2 degradation by dioscin reprogrammes aerobic glycolysis and inhibits colorectal cancer cells growth
BACKGROUND: The F-box protein S-phase kinase-associated protein 2 (Skp2) is overexpressed and correlated with poor prognosis in human malignancies, including colorectal cancer (CRC). METHODS: A natural product library was used for natural compound screening through glycolysis analysis. The expressio...
Autores principales: | Zhou, Li, Yu, Xinfang, Li, Ming, Gong, Guanghui, Liu, Wenbin, Li, Tian, Zuo, Huilan, Li, Wei, Gao, Feng, Liu, Haidan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000337/ https://www.ncbi.nlm.nih.gov/pubmed/31806563 http://dx.doi.org/10.1016/j.ebiom.2019.11.031 |
Ejemplares similares
-
Skp2 stabilizes Mcl-1 and confers radioresistance in colorectal cancer
por: Yu, Xinfang, et al.
Publicado: (2022) -
Xanthohumol inhibits colorectal cancer cells via downregulation of Hexokinases II-mediated glycolysis
por: Liu, Wenbin, et al.
Publicado: (2019) -
Dioscin: A new potential inhibitor of Skp2 for cancer therapy
por: Jiang, Wenxiao, et al.
Publicado: (2020) -
Skp2-mediated MLKL degradation confers cisplatin-resistant in non-small cell lung cancer cells
por: Zhou, Huiling, et al.
Publicado: (2023) -
Gastrodin overcomes chemoresistance via inhibiting Skp2-mediated glycolysis
por: Xie, Li, et al.
Publicado: (2023)